Sarepta Therapeutics Inc.

(SRPT) Trade

By |

Profile

Sarepta Therapeutics Inc is a biotechnology company. It uses proprietary RNA-targeted technology platforms for developing pharmaceutical products to address serious diseases.

Contact Information

Website: www.sarepta.com
Email: investors@sarepta.com
Main Phone: +1 617 274-4000
Address: 215 First Street
Address 2: Suite 415
State: MA
City / Town: Cambridge
Country: USA
Postal Code: 02142

Issuer Information

Exchange: NGS
CEO: Douglas S. Ingram
Employees: 255
NAICS: Pharmaceutical Preparation Manufacturing (325412)
$ 136.87 $ 0.19 (0.14%)
Last Price 136.87 Change $ 0.19 Change % 0.14 Tick N/A
Bid 136.00 Bid Size 100.00 Ask 137.00 Ask Size 100.00
Open 135.15 High 137.29 Low 133.50 Prev Close 136.68
Last Trade Volume 80,659 52 Wk Hi 176.50 52 Wk Low 32.80
Market Cap 9 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 65,531,046.00 EPS (TTM) -2.87 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 8 76
Number of Buys 4 43
Number of Sells 4 33
Net Activity 14946 491537
Last 10 Buys Shares
Douglas S. Ingram 1,000
Douglas S. Ingram 1,000
M. Kathleen Behrens 1,000
M. Kathleen Behrens 1,000
Richard J. Barry 1,000
Gil Price 1,000
Christopher Garabedian 1,000
Edward M. Kaye 1,000
Anthony R. Chase 1,000
M. Kathleen Behrens 1,000
Last 10 Sell Shares
Hans Wigzell 1,000
Shamim Ruff 1,000
Shamim Ruff 1,000
Shamim Ruff 1,000
Shamim Ruff 1,000
Sandesh Mahatme 1,000
Sandesh Mahatme 1,000
David T. Howton 1,000
David T. Howton 1,000
Sandesh Mahatme 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 121 121 121 121
Low Target Price Estimate 64 64 64 64
Mean Target Price Estimate 96.83 95.75 95.75 96.83
Standard Deviation 14.56 14.38 14.38 14.56
Date of Most Recent Estimate 06/01/18 05/14/18 05/14/18 06/01/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 11 11 11 11
Moderate Buy 2 2 2 3
Hold 2 2 2 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.4 1.4 1.4 1.3